Prana Biotechnology Ltd Sponsored ADR
(NASDAQ : PRAN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading PRAN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.18%165.741.2%$762.85m
INCYIncyte Corporation
0.48%139.641.7%$625.40m
GILDGilead Sciences, Inc.
0.03%67.511.0%$573.84m
CELGCelgene Corporation
0.13%123.381.0%$496.94m
BIIBBiogen Inc.
-0.21%274.821.3%$454.02m
REGNRegeneron Pharmaceuticals, Inc.
2.19%373.002.1%$318.70m
KITEKite Pharma, Inc.
3.14%76.8418.8%$216.10m
ALXNAlexion Pharmaceuticals, Inc.
-0.83%119.261.6%$202.32m
TSROTESARO, Inc.
4.15%160.0016.1%$185.28m
ILMNIllumina, Inc.
1.72%170.583.7%$170.76m
ESPREsperion Therapeutics, Inc.
-3.61%38.9418.7%$166.57m
AUPHAurinia Pharmaceuticals Inc.
-4.41%8.026.3%$143.97m
CLVSClovis Oncology, Inc.
2.61%70.3217.5%$141.44m
VRTXVertex Pharmaceuticals Incorporated
1.04%89.982.2%$134.68m
EXELExelixis, Inc.
2.95%20.917.0%$105.35m

Company Profile

Prana Biotechnology Ltd. engages in the development of therapies to treat neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.